A circulating biomarker of facioscapulohumeral muscular dystrophy clinical severity, valid in skeletal muscle and blood
Christopher R. S. Banerji, Anna Greco, Leo A. B. Joosten, Baziel G.M. van Engelen, Peter S. Zammit
The paper identifies a circulating transcriptomic biomarker in blood that correlates with FSHD clinical severity and validates it in muscle tissue.
bioRxiv · Aug 31, 2022 · PreprintBioinformatics